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CLINICAL STUDIES Cardiac Catheterization and Intervention
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OBJECTIVES We sought to evaluate whether coronary collateral flow is clinically relevant for future cardiac
ischemic events.
BACKGROUND The link between good collateral supply related to less myocardial damage and fewer cardiac
events has not been established prospectively beyond doubt.
METHODS In 403 patients with stable angina pectoris undergoing percutaneous transluminal coronary
angioplasty (PTCA) and quantitative collateral assessment, the occurrence of major adverse
cardiac events ([MACE] cardiac death, myocardial infarction, unstable angina pectoris) and
stable angina pectoris was monitored during follow-up. Collateral flow index (CFI) was
determined using intracoronary pressure or Doppler guidewires. Mean aortic ([Pao] mm Hg)
and distal coronary artery occlusive pressure ([Poccl] mm Hg) during balloon angioplasty
(PTCA), or distal coronary flow velocity time integral during ([Voccl] cm) and after ([Vø-occl]
cm) PTCA were measured continuously. Pressure-derived CFI was calculated as follows:
(Poccl  5)/(Pao  5). Doppler-derived CFI: Voccl/Vø-occl. Patients were subdivided into a
group with well (CFI  0.25) and poorly developed collaterals (CFI  0.25).
RESULTS Average follow-up was 94  56 (15 to 202) weeks. There were 134 patients with CFI 0.25
(61  11 years) and 269 with CFI 0.25 (61  10 years). The overall cardiac ischemic event
rate (MACE and stable angina pectoris) during follow-up was 23% in patients with CFI
0.25 and 20% in patients with CFI 0.25 (p  NS). However, only 2.2% of patients with
good collateral flow suffered a major cardiac ischemic event, compared with 9.0% among
patients with poorly developed collaterals (p  0.01). The incidence of stable angina pectoris
was significantly higher in patients with well developed collaterals than in those with poorly
developed collaterals (21% vs. 12%; p  0.01).
CONCLUSIONS In this relatively large population with chronic stable coronary artery disease undergoing
quantitative collateral measurement, the beneficial impact of well developed collateral vessels
on the occurrence of future major cardiac ischemic events is clearly demonstrated. (J Am
Coll Cardiol 2002;40:1545–50) © 2002 by the American College of Cardiology Foundation
In the situation of an acute coronary artery occlusion, well
developed collateral vessels have been demonstrated to
reduce myocardial infarct (MI) size, to protect against
ventricular aneurysm formation, and to improve systolic
ventricular function (1,2). Theoretically, those beneficial
effects from a well developed collateral circulation should
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directly translate into a markedly lower incidence of future
cardiac ischemic events among patients with jeopardized
coronary vascular territories. The link between good collat-
eral supply related to less myocardial damage and fewer
cardiac events has not been established prospectively beyond
doubt. This may be explained by the fact that previous
clinical studies on the relationship between coronary collat-
erals and cardiac events lack quantitative means for collateral
measurements (3–7) or sufficient patient numbers (8). The
hypothesis of this study was that there is a beneficial impact
of well developed collaterals on the occurrence of future
major cardiac ischemic events. Thus, it was the purpose of
our study to examine the influence of quantitatively deter-
mined collaterals on ischemic events in a cohort of more
than 400 patients with stable coronary artery disease
(CAD).
METHODS
Patients. A total of 403 patients (age, 61  11 years; 311
men, 92 women) with one- or two-vessel CAD were
included in the study. All patients underwent percutaneous
transluminal coronary angioplasty (PTCA) for clinical pur-
poses (stable angina pectoris or positive exercise test with
electrocardiogram [ECG] ST-segment depression).
The study population was subdivided into a group with
well (i.e., high collateral flow index [CFI] 0.25) and
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poorly developed collaterals (i.e., low collateral flow index,
CFI  0.25) according to the pressure- or Doppler-derived
CFI.
This investigation was approved by the local ethics
committee, and all patients gave informed consent to
participate in the investigation. The patients included in this
study have been described, in part, elsewhere (9).
Coronary angiography. Patients underwent left heart
catheterization and coronary angiography for diagnostic
purposes. Aortic pressure was measured using the 6F
guiding catheter. Biplane left ventricular angiography was
performed followed by diagnostic coronary angiography.
Coronary artery lesions were estimated quantitatively as
percent diameter reduction. Angiographic collateral degree
(0 to 3) was determined according to the extent of epicardial
coronary artery filling via collaterals with contrast medium
from the contralateral side before PTCA (10). Patients were
divided into two groups: 1) no or low angiographic collateral
degree (0 to 1); or 2) high angiographic collateral degree (2
to 3).
Coronary collateral assessment. PRESSURE-DERIVED
CFI. A fiberoptic pressure-sensored 0.014-in. PTCA guide-
wire (WaveWire, Jomed, Switzerland) was used to deter-
mine pressure-derived CFI (CFIP) by simultaneous mea-
surement of mean aortic pressure ([Pao], mm Hg, via the
angioplasty guiding catheter) and the distal coronary artery
perfusion pressure during balloon occlusion (i.e., coronary
wedge pressure [Poccl] mm Hg) (Fig. 1). Central venous
pressure (CVP) was estimated to be equal to 5 mm Hg;
CFIP was calculated as (Poccl  CVP)  (Pao  CVP).
DOPPLER-DERIVED CFI. Doppler flow velocity measure-
ments were performed using a 0.014-in. PTCA Doppler
guidewire with a 12-MHz piezoelectric crystal at its tip
Abbreviations and Acronyms
CAD  coronary artery disease
CFI  collateral flow index
CFIP  pressure-derived index of collateral flow
CFIV  velocity-derived index of collateral flow
CVP  central venous pressure
i.c.  intracoronary
MI  myocardial infarct, myocardial infarction
Pao  mean aortic pressure
Poccl  coronary wedge pressure
PTCA  percutaneous transluminal coronary angioplasty
Voccl  ratio of flow velocity time integral distal to the
occluded stenosis
Vø-occl  flow velocity time integral during vessel patency
Figure 1. Simultaneous determination of intracoronary flow velocity (cm/s) and pressure (mm Hg) measurements. The flow velocity trend over 90 s is
shown during vessel occlusion (Voccl) and during vessel patency (Vø-occl) in the left upper panel of the figure. In the upper part, the instantaneous flow
velocity signal (cm/s) during vessel occlusion is represented. On the right, simultaneous aortic (Pao) and distal occlusive (Poccl) pressure is shown. The
pressure-derived collateral flow index (CFIP) was calculated as follows: (Poccl  5)/(Pao  5). Doppler-derived CFIV: Voccl/Vø-occl. CFIv  velocity-derived
index of collateral flow.
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(FloWire, Jomed, Switzerland). The velocity-derived index
of collateral flow (CFIV) was determined as the ratio of flow
velocity time integral distal to the occluded stenosis ([Voccl]
cm)  flow velocity time integral during vessel patency
([Vø-occl] cm) obtained at identical wire location 1 to 4 min
after PTCA when the hyperemic response was abolished
and the flow velocity signal was again constant over 30 s:
Voccl/Vø-occl (11). In patients with bidirectional flow velocity
signals, they were added to obtain total collateral flow
velocity integral.
The validation of the pressure- and Doppler-derived CFI
has been described previously (11).
Study protocol. After diagnostic coronary angiography, an
interval of at least 10 min was allowed for dissipation of the
effect of the nonionic contrast medium (iopamidol 755
mg/mL) on coronary flow velocity and vasomotion. An
intracoronary (i.c.) bolus of 0.2 mg of nitroglycerin was
given in order to maintain epicardial coronary artery caliber
constant and, thus, to eliminate dimensional changes of the
epicardial vessels that may influence collateral flow indexes.
The pressure or Doppler guidewire was positioned distal to
the stenosis to be dilated. Coronary and aortic pressure or
flow velocity were measured continuously. During the entire
protocol, an i.c. ECG obtained from the guidewire, a
three-lead surface ECG, and blood pressure were recorded.
After a follow-up period of 94  56 weeks (minimum 12
weeks), all patients or the attending physician were con-
tacted about cardiac ischemic events (i.e., cardiac death, MI,
unstable and stable angina pectoris).
Statistical analysis. Between-group comparison of contin-
uous angiographic, hemodynamic, and collateral data was
performed by an unpaired two-sided Student t test (inde-
pendent sample t test). A chi-square test was used for
comparison of categorical variables among the two study
groups, and event analysis was performed by Kaplan-Meier
analysis. Statistical significance was defined as a p value of
0.05.
RESULTS
Patient characteristics. There were no statistically signif-
icant differences among the two groups with well and poorly
developed collateral vessels with regard to patient age,
gender, hemodynamic variables during cardiac catheteriza-
tion (heart rate and blood pressure), frequency of cardiovas-
cular risk factors, and vasoactive drugs used (Table 1).
Angiographic and coronary collateral data. In the group
with CFI 0.25, the severity of the dilated stenosis was
higher and more vessels were affected by CAD than in the
group with CFI 0.25. No statistical difference was deter-
mined between the groups regarding left ventricular ejection
fraction (Table 2). In addition, the occurrence of angina
pectoris and ST-segment changes on i.c. ECG during
balloon occlusion was significantly lower in the group with
CFI 0.25 than in the group with CFI 0.25.
Follow-up data and event rate. Follow-up ranged be-
tween 15 to 202 weeks (mean: 94  56). Follow-up
duration was significantly longer in the group with CFI
0.25 than with CFI 0.25 (Table 3). Only 2.2% of the
patients with good collateral flow suffered a major cardiac
ischemic event as compared with 9.0% among patients with
poor collaterals (p  0.01, Fig. 2). All major cardiac events
in both groups occurred within the first year after PTCA
(Fig. 3). Regarding the overall event rate, there was no
statistically significant difference between the two groups:
23% and 20% (Table 3, Fig. 4). However, the incidence of
minor ischemic events defined as chronic stable angina was
significantly higher in patients with well developed com-
pared with patients with poorly developed collaterals (21%
vs. 12%; p  0.01; Table 3, Fig. 4).
DISCUSSION
This sizeable prospective study in patients with stable CAD
undergoing collateral flow measurement during PTCA
documents a fourfold reduced rate of major adverse cardiac
events during follow-up in individuals with well versus
poorly grown collateral vessels. This appears to challenge
other investigations of the predictive value of the collateral
circulation.
Controversy in the literature about the protective effect
of the collateral circulation. The ongoing controversy over
whether coronary collateral vessels are protective with re-
spect to future cardiac events is substantially related to
common methodological problems such as relatively low
numbers of individuals included in the studies (3–6,12,13),
short observation periods (13–15), and use of surrogate end
points for cardiac events such as systolic left ventricular
function (4,12,13,15). More specifically, it probably has to
do with the blunt instrument for assessing the collateral
circulation used in most of the approximately 10 recent
studies on the topic, namely coronary angiography (3–
7,13,14). Also, among the majority of the studies just
Table 1. Clinical Characteristics
CFI > 0.25 CFI < 0.25 p Value
Number of patients 134 269
Age (yrs) 61  11 61  10 NS
Men (%) 103 (77) 208 (77) NS
Smoking (%) 64 (48) 99 (37) NS
Diabetes mellitus (%) 22 (16) 41 (15) NS
Family history of CAD (%) 48 (36) 89 (33) NS
Obesity (%) 24 (18) 56 (21) NS
Systemic hypertension (%) 64 (48) 140 (52) NS
Hypercholesterolemia (%) 65 (49) 126 (47) NS
Acetylsalicylic acid (%) 117 (87) 219 (81) NS
Beta-blockers (%) 84 (63) 159 (59) NS
Calcium antagonists (%) 24 (18) 47 (17) NS
Lipid-lowering agents (%) 42 (31) 90 (33) NS
ACE inhibitors (%) 28 (21) 71 (26) NS
Nitrates (%) 54 (40) 101 (38) NS
ACE  angiotensin-converting enzyme; CAD  coronary artery disease; CFI 
collateral flow index.
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mentioned, angiographic collateral qualification has been
performed to look for spontaneously visible instead of
recruitable collaterals, the latter of which appear in response
to occlusion of the collateral receiving vessel and, thus,
reflect collateral supply more comprehensively than the
former. These problems have been overcome by the present
investigation, that is, in more than 400 patients with an
average follow-up of almost two years, quantitative assess-
ment of collateral flow during coronary balloon occlusion
was performed before documenting major as well as minor
(i.e., stable angina pectoris) adverse cardiac events.
Aside from the mentioned statistical and technical factors
that are likely to have contributed to the fact that three of
the 10 cited studies have described no effect or an adverse
effect of collaterals on outcome (5–7), biological situations
at variance to those chosen in our study design have
probably caused contradicting results. Those conditions
include selection of the study baseline during acute MI
(7,13–15), of patients with chronic (3–6) or without infarc-
tion (8,12), focus on collaterals present at the time of
(7,13–15) or developing after (3–6) acute MI, or investiga-
tion of patients with chronic total occlusions (3–5,12),
balloon occluded vessels (8,15), or residual stenoses after
thrombolysis (7).
In the setting of acute MI, the rate of subsequent
ischemic events during the first months of follow-up is
much higher (cardiac mortality of 4% to 9% within six
months after MI [14]), as compared with chronic stable
CAD (mortality of 0.5% to 1%/1.8 years of follow-up in our
study). Thus, our study design is very conservative with
regard to the zero hypothesis that collaterals do not have a
protective influence on future cardiac events. Accordingly,
the finding that overall major cardiac events and the rate of
MI were significantly lower in patients with good versus
poor collaterals weighs substantially.
The collateral circulation as indicator of the severity of
CAD. Using the model of early infarct artery collateral flow
after thrombolysis, confusing study results can be found
even within a single investigation. In their recently pub-
lished study, Nicolau et al. (7) found antegrade flow to be
directly, but collateral flow to the same acutely infarcted area
to be inversely, associated with survival. With regard to
myocardial perfusion, this finding does not make sense,
because it must be entirely irrelevant whether an ischemic
territory is supplied via native or via collateral vessels as long
as it is adequately subtended. The investigation by Nicolau
et al. (7) and by Gohlke et al. (6) were both designed in a
way that angiographic collateral degree was a marker for the
culprit residual lesion severity rather than an independent
variable for “bypass flow.” The degree of a coronary stenosis
is the strongest (although still quite weak) predictor for the
status of the human collateral circulation (9). Thus, a tight
residual coronary stenosis after thrombolytic therapy is
related to enhanced collateral flow, but also to impaired
antegrade flow, the latter of which has been documented to
be the main determinant of outcome in the mentioned
setting (6).
Table 2. Angiographic and Coronary Collateral Data
CFI > 0.25 CFI < 0.25 p Value
Number of patients 134 269
Number of vessels diseased 2.0  0.8 1.8  0.7 0.04
Percent diameter stenosis 83  15 79  13 0.009
LAD/LCX/RCA undergoing PTCA 78/26/30 173/45/51 NS
Left ventricular ejection fraction (%) 65  11 65  11 NS
Coronary collateral data
Angina pectoris during PTCA 54 (40%) 177 (66%)  0.0001
ST-segment changes during PTCA 33 (25%) 230 (86%)  0.0001
CFI 0.39  0.14 0.14  0.07
Velocity-derived CFI (n  207) 0.41  0.16 0.15  0.06
Pressure-derived CFI (n  196) 0.37  0.12 0.13  0.07
CFI  collateral flow index; LAD  left anterior descending coronary artery; LCX  left circumflex coronary artery; PTCA 
percutaneous transluminal coronary angioplasty; RCA  right coronary artery.
Table 3. Cardiac Ischemic Events
CFI > 0.25 CFI < 0.25 p Value
Number of patients 134 269
Follow-up (weeks) 105  64 85  52 0.001
Time to event (weeks) 9  9 15  13 NS
All events (UAP, MI, death, SAP) 31 (23%) 55 (20%) NS
Major cardiac ischemic events 3 (2.2%) 24 (9.0%) 0.01
Death 1 (0.7%) 1 (0.3%) NS
MI 0 (0%) 11 (4.1%) 0.02
UAP 2 (1.5%) 12 (4.5%) 0.13
SAP 28 (21%) 31 (12%) 0.01
CFI  collateral flow index; MI  myocardial infarction; SAP  stable angina pectoris; UAP  unstable angina pectoris.
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The collateral circulation as predictor of future cardiac
ischemic events. In order to control for covariables such as
residual stenosis influencing the study results aside from the
factor of interest (i.e., collateral flow), it is mandatory that a
model with uniform stenosis severity is used. Such a
condition is fulfilled either in the presence of a completely
obstructed or entirely patent coronary artery. Using the
model of chronic total occlusion after acute MI, Boehrer
and coworkers (5) found no advantage of present versus
absent angiographic collaterals with regard to future cardiac
events (annual cardiac mortality, 4.3% and 5.4%, respec-
tively, mean follow-up duration, 42 months). This result is
Figure 2. Individual collateral flow index values (vertical axis) divided into five categories (horizontal axis): patients without any cardiac ischemic event
during the follow-up period (left side); patients with major adverse cardiac ischemic events (MACE); patients with unstable angina pectoris (UAP); patients
with myocardial infarction (MI); patients who died (Death).
Figure 3. Cumulative event rate analysis (vertical axis): time to the
occurrence of a major adverse cardiac ischemic event (death, myocardial
infarction, or unstable angina pectoris) during follow-up. Only three
patients (2%) with good collaterals, but 24 patients (9%) with poor
collaterals, suffered a major adverse cardiac ischemic event during the first
year after successful percutaneous transluminal coronary angioplasty.
CFI  collateral flow index.
Figure 4. Frequency of cardiac ischemic events (vertical axis): the overall
event rate was not different between the two groups. Only 2.2% of the
patients with high collateral flow suffered a major adverse cardiac ischemic
event compared with 9.0% of the patients with poor collaterals (p  0.01).
However, the incidence of angina pectoris was significantly higher in
patients with abundant compared with patients with scarce collaterals (21%
vs. 12%; p  0.01). CFI  collateral flow index.
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most likely due to the fact that a majority of the 146 study
patients with widely varying collaterals have been compared
with a minority of 26 patients without collaterals. In the
setting of total coronary occlusion without acute MI, Juil-
liere et al. (12) and Hansen (3) both found angiographically
estimated, well developed collaterals to have a positive effect
on future cardiac events. The advantage of the chronic
occlusion model (i.e., the ability to investigate exclusively
the effect of collateral flow on outcome) has certainly not
been met with a study design like ours, whereby the
influence on outcome of possibly developing restenosis after
PTCA with collateral measurement cannot be excluded. In
favor of restenosis as a covariable on adverse events is that
practically all of them took place within the first seven
months after PTCA (Fig. 3). Unfortunately, angiographic
follow-up was not performed in our study to test such a
possibility. The fact that angina pectoris occurred more
often in the group with well versus poorly developed
collaterals (Fig. 4) may also be in favor of restenosis as a
cofactor of outcome aside from collateral flow; high collat-
eral flow obtained during PTCA representing a risk factor
for restenosis is in accordance with the mentioned consid-
erations (16). However, despite all these arguments, it was
the group with low collateral flow (linked to low degree
stenotic lesion severity) that showed the higher frequency of
adverse cardiac events and not vice versa. Thus, the in-
creased frequency of angina pectoris in the group with CFI
0.25 may be interpreted as an indicator of enhanced
collateral growth as it has been described previously (17).
Study limitations. Aside from the limitations of our study
alluded to above, the completeness of follow-up is one that
has to be considered. In 43 of 446 potentially eligible
patients, follow-up was lost. These patients were not in-
cluded into the study. Follow-up by direct interview of the
patient was not possible in 77 of the 403 patients (19%; 8%
in the group with CFI  0.25, respectively, 11% in the
group with CFI  0.25; p  NS). Consequently, the
attending physician was contacted who may not have been
correctly informed about the current status of the patient.
However, he would have most likely known about a severe
adverse cardiac event occurring to the patient.
Central venous pressure was not measured in most
patients with pressure-derived CFI. However, in a popula-
tion of 161 patients undergoing CFIP measurements, CVP
was also obtained. In these patients, CVP was equal to 6.5
 3.8 mm Hg (range, 1 to 22 mm Hg). The standard error
of estimate relative to average CFI was 7.7% (standard error
of estimate, 0.016). Therefore, the error of calculating CFI
by an assumed CVP appears to be rather small with regard
to the present, large study population.
Follow-up duration differed significantly among the study
groups. However, because it was shorter in the group with
an increased rate of major adverse cardiac events, the weight
of the finding of a negative effect of low collateral flow in the
mentioned group is even more pronounced than it would be
with similar observation periods.
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